CSIMarket Company Name, Ticker, Competitors, else..


Bristol myers Squibb Company  (BMY)
Other Ticker:  
 

Bristol myers Squibb Company

BMY's Fundamental analysis



Bristol Myers Squibb's sales fell by -2.67 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 326

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.24 %

Bristol Myers Squibb's net income grew by 76.7 % in I. Quarter 2023 year on year, above company average,

• More on BMY's Growth


Bristol Myers Squibb
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Bristol Myers Squibb PEG ratio is at 0.9 Bristol Myers Squibb realized cash outflow of $ -1.67per share in trailing twelve-month period.
Company
19.33
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 3.06.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.19.


• More on BMY's Valuation
 
 Total Debt (Millions $) 37,830
 Dividend TTM ($) 2.17 $
 Dividend Yield TTM (%) 3.41 %
 Revenue/Employee (TTM) $ 1,423,851
 Net Income/Employee (TTM) $ 227,609
 Receivable Turnover (TTM) 4.75
 Tangible Book Value (Per Share $) -10.81

Bristol Myers Squibb
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Bristol Myers Squibb PEG ratio is at 0.9 Bristol Myers Squibb realized cash outflow of $ -1.67per share in trailing twelve-month period.
Company
19.33
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 3.06.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.19.

Bristol Myers Squibb Price to Book Ratio is at 4.4 higher than Indusry Avg. of -1027.04, and lower than S&P 500 Avg. of 1354.72

• More on BMY's Valuation

•  Market Capitalization (Millions $) 140,155
•  Shares Outstanding (Millions) 2,114
•  Employees 32,200
•  Revenues (TTM) (Millions $) 45,848
•  Net Income (TTM) (Millions $) 7,329
•  Cash Flow (TTM) (Millions $) -3,531
•  Capital Exp. (TTM) (Millions $) -1,143
•  Total Debt (Millions $) 37,830
•  Dividend TTM ($) 2.17 $
•  Dividend Yield TTM (%) 3.41 %
•  Revenue/Employee (TTM) $ 1,423,851
•  Net Income/Employee(TTM) $ 227,609
•  Receivable Turnover Ratio (TTM) 4.75
•  Tangible Book Value (Per Share $) -10.81

•  Market Capitalization (Millions $) 140,155
•  Shares Outstanding (Millions) 2,114
•  Employees 32,200
•  Revenues (TTM) (Millions $) 45,848
•  Net Income (TTM) (Millions $) 7,329
•  Cash Flow (TTM) (Millions $) -3,531
•  Capital Exp. (TTM) (Millions $) -1,143


    BMY's Profitability Comparisons
Bristol Myers Squibb achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2023 to 20.79 % from 14.4 % in IV. Quarter.

Bristol Myers Squibb net profit margin of 20 % is currently ranking no. 20 in Major Pharmaceutical Preparations industry, ranking no. 47 in Healthcare sector and number 756 in S&P 500.


Profitability by Segment
Total Pharmaceuticals 17.94 %



  Ratio
•   Capital Ratio (MRQ) 1.42
•  Total Debt to Equity (MRQ) 1.19
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.47
•  Inventory Turnover Ratio (TTM) 4.47



Bristol Myers Squibb achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2023 to 20.79 % from 14.4 % in IV. Quarter.

Bristol Myers Squibb net profit margin of 20 % is currently ranking no. 20 in Major Pharmaceutical Preparations industry, ranking no. 47 in Healthcare sector and number 756 in S&P 500.

• More on BMY's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071